Lidocaine Hydrochloride And Dextrose Injection, Solution
Product Images NDC 0338-0409

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride And Dextrose (NDC 0338-0409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lidocaine Hydrochloride, Usp And D-glucose Monohydrate Structural Formula Images (Image 01)

Chemical structure diagram showing Lidocaine Hydrochloride and D-Glucose monohydrate, the active ingredients in Lidocaine Hydrochloride and Dextrose injection. The diagram includes structural formulas labeled with their chemical names.*

FDA Label Image

Lidocaine Hydrochloride Representative Container Label Ndc 0338-0411-02 (Image 02)

Label for Lidocaine Hydrochloride and 5% Dextrose Injection USP, 8 mg/mL (2 g per 250 mL), sterile single dose container. The label includes dosage concentration, storage instructions, and warnings. It is manufactured by Baxter Healthcare Corporation, USA.*

FDA Label Image

Lidocaine Hydrochloride 0338-0411-02 Representative Carton Label (Image 03)

Label for Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 g per 250 mL solution. The label shows lot number T123456, expiration date January 2020, quantity 24 bottles of 250 mL each, and includes a barcode. Manufactured by Baxter Healthcare Corporation.*

FDA Label Image

Lidocaine Hydrochloride Representative Container Label Ndc0338-0409-03 (Image 04)

Label for Lidocaine Hydrochloride and 5% Dextrose Injection USP, 4 mg/mL (2 g per 500 mL) intravenous solution. The sterile single-dose container holds 500 mL. The label includes instructions about dosage concentration, storage conditions, and usage restrictions. Manufactured by Baxter Healthcare Corporation.*

FDA Label Image

Lidocaine Hydrochloride Representative Carton Label 0338-0409-03 (Image 05)

Label for Lidocaine Hydrochloride and 5% Dextrose Injection, USP 2 g per 500 mL solution. The label includes the lot number, expiration date (January 2020), barcode, and NDC code 0338-0409-03. The product is an intravenous injection solution by Baxter Healthcare Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.